Atara Biotherapeutics (ATRA)
NASDAQ:ATRA

Atara Biotherapeutics (ATRA) Income Statement

1,079 Followers

Atara Biotherapeutics Income Statement

Last quarter (Q1 2024), Atara Biotherapeutics's total revenue was $27.36M, an increase of Infinity% from the same quarter last year. In Q1, Atara Biotherapeutics's net income was $-31.75M. See Atara Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 30.45M$ 8.57M--$ 0.00$ 0.00
Cost of Revenue
$ -2.62M-----
Gross Profit
$ 33.07M$ 8.57M----
Operating Expense
$ 274.37M$ 266.81M$ 344.09M$ 340.46M$ 309.05M$ 295.68M
Operating Income
$ -242.73M$ -258.23M$ -280.51M$ -340.46M$ -309.05M$ -295.68M
Net Non Operating Interest Income Expense
$ -5.26M$ -5.29M$ -373.00K$ 29.00K$ 2.45M$ 4.72M
Other Income Expense
$ -1.06M$ 246.00K$ -1.99M$ -367.00K--
Pretax Income
$ -247.40M$ -258.34M$ -228.29M$ -340.10M$ -306.61M$ -290.96M
Tax Provision
$ 28.00K$ 15.00K$ 12.00K$ 46.00K$ 15.00K$ 12.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -242.20M$ -258.35M$ -228.28M$ -340.14M$ -306.62M$ -290.98M
Basic EPS
$ -2.29$ -2.61$ -2.24$ -3.63$ -4.15$ -5.67
Diluted EPS
$ -2.29$ -2.61$ -2.24$ -3.63$ -4.15$ -5.67
Basic Average Shares
$ 456.05M$ 105.91M$ 101.99M$ 93.67M$ 73.97M$ 51.31M
Diluted Average Shares
$ 456.05M$ 105.91M$ 101.99M$ 93.67M$ 73.97M$ 51.31M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 271.75M$ 266.81M$ -344.09M$ 340.46M$ 309.05M$ 295.68M
Net Income From Continuing And Discontinued Operation
$ -247.43M$ -258.35M$ -228.30M$ -340.14M$ -306.62M$ -290.98M
Normalized Income
$ -152.67M$ -204.67M--$ -306.62M$ -290.98M
Interest Expense
------
EBIT
$ -267.51M$ -253.05M$ -228.29M$ -340.12M$ -309.05M$ -295.68M
EBITDA
$ -262.50M$ -248.22M$ -222.59M$ -330.82M$ -300.72M$ -288.61M
Currency in USD

Atara Biotherapeutics Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis